Free Trial

OPKO Health (OPK) Competitors

$1.36
+0.08 (+6.25%)
(As of 05/24/2024 ET)

OPK vs. INVA, IRWD, MNKD, LXRX, PCRX, DVAX, ADCT, VSTM, AVIR, and VNDA

Should you be buying OPKO Health stock or one of its competitors? The main competitors of OPKO Health include Innoviva (INVA), Ironwood Pharmaceuticals (IRWD), MannKind (MNKD), Lexicon Pharmaceuticals (LXRX), Pacira BioSciences (PCRX), Dynavax Technologies (DVAX), ADC Therapeutics (ADCT), Verastem (VSTM), Atea Pharmaceuticals (AVIR), and Vanda Pharmaceuticals (VNDA). These companies are all part of the "pharmaceutical preparations" industry.

OPKO Health vs.

OPKO Health (NASDAQ:OPK) and Innoviva (NASDAQ:INVA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

Innoviva has lower revenue, but higher earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Innoviva, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OPKO Health$863.50M1.05-$188.86M-$0.35-3.70
Innoviva$310.46M3.16$179.72M$2.227.09

Innoviva has a net margin of 58.21% compared to OPKO Health's net margin of -31.44%. Innoviva's return on equity of 28.94% beat OPKO Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OPKO Health-31.44% -17.89% -12.26%
Innoviva 58.21%28.94%15.39%

OPKO Health presently has a consensus price target of $3.17, suggesting a potential upside of 144.53%. Given OPKO Health's higher probable upside, research analysts plainly believe OPKO Health is more favorable than Innoviva.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OPKO Health
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Innoviva
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

64.6% of OPKO Health shares are held by institutional investors. Comparatively, 99.1% of Innoviva shares are held by institutional investors. 47.3% of OPKO Health shares are held by insiders. Comparatively, 1.4% of Innoviva shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

OPKO Health has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Comparatively, Innoviva has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

In the previous week, OPKO Health had 9 more articles in the media than Innoviva. MarketBeat recorded 10 mentions for OPKO Health and 1 mentions for Innoviva. Innoviva's average media sentiment score of 1.56 beat OPKO Health's score of 1.34 indicating that Innoviva is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OPKO Health
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Innoviva
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

OPKO Health received 203 more outperform votes than Innoviva when rated by MarketBeat users. Likewise, 65.79% of users gave OPKO Health an outperform vote while only 57.28% of users gave Innoviva an outperform vote.

CompanyUnderperformOutperform
OPKO HealthOutperform Votes
498
65.79%
Underperform Votes
259
34.21%
InnovivaOutperform Votes
295
57.28%
Underperform Votes
220
42.72%

Summary

Innoviva beats OPKO Health on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPK vs. The Competition

MetricOPKO HealthPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$902.60M$6.73B$5.00B$8.05B
Dividend YieldN/A2.73%2.81%3.93%
P/E Ratio-3.7011.55133.4015.40
Price / Sales1.05258.712,452.2675.54
Price / CashN/A35.7135.9531.61
Price / Book0.725.925.434.60
Net Income-$188.86M$139.39M$104.34M$213.88M
7 Day Performance-1.89%-2.25%-1.47%-1.28%
1 Month Performance5.28%1.56%2.64%2.96%
1 Year Performance-13.09%-6.51%3.36%7.62%

OPKO Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INVA
Innoviva
1.4532 of 5 stars
$16.15
+0.1%
N/A+16.6%$1.01B$310.46M7.27112Positive News
IRWD
Ironwood Pharmaceuticals
4.3818 of 5 stars
$6.78
+5.6%
$18.40
+171.4%
-44.8%$1.06B$442.73M-1.00267Analyst Revision
MNKD
MannKind
3.0375 of 5 stars
$4.74
+0.9%
$8.00
+68.8%
+3.4%$1.29B$198.96M158.05411Insider Selling
LXRX
Lexicon Pharmaceuticals
0.9459 of 5 stars
$1.67
-5.6%
$5.00
+199.4%
-47.4%$411.22M$1.20M-2.01285
PCRX
Pacira BioSciences
4.9229 of 5 stars
$30.90
+0.9%
$47.40
+53.4%
-27.0%$1.44B$674.98M21.61711Positive News
DVAX
Dynavax Technologies
4.2717 of 5 stars
$11.46
+0.6%
$25.33
+121.1%
+6.9%$1.50B$232.28M191.00408Gap Down
ADCT
ADC Therapeutics
2.5473 of 5 stars
$3.73
-9.2%
$7.25
+94.4%
+42.7%$308.76M$68.62M-1.36273
VSTM
Verastem
2.0419 of 5 stars
$12.06
+3.9%
$28.79
+138.7%
+121.5%$305.48M$2.60M-2.7473News Coverage
Gap Down
High Trading Volume
AVIR
Atea Pharmaceuticals
0.5384 of 5 stars
$3.61
+0.3%
N/A-25.2%$304.03M$351.37M-1.8474
VNDA
Vanda Pharmaceuticals
1.3358 of 5 stars
$5.11
-3.0%
N/A-22.1%$297.40M$192.64M-63.88203Positive News

Related Companies and Tools

This page (NASDAQ:OPK) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners